Loading clinical trials...

Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings | Clinical Trials | Clareo Health

COMPLETEDNA

Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings

NCT01735708•Butler Hospital

Summary

The purpose of this study is to determine whether participation in the study intervention, which involves collaboration between the study interventionist and the participant's primary care physician, will reduce symptoms of pain and depression in HIV+ patients.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Chronic Pain (pain duration for at least six months with a mean score of 5 or higher on the BPI Pain Interference Scale)
•Pain severity of 40 or higher on a Visual Analog Scale (0-100) indicating "worst pain in the last week"
•At least one trial of PCP-recommended medication (i.e. acetominophen, NSAIDS, skeletal muscle relaxants) judged through interviews with patients and PCPs
•QIDS score of ≥ 9 (depression severity)
•Stable dose of an antidepressant, if using, for the previous 2 months
•Age 18 or older
•HIV+

Exclusion Criteria

•Lifetime DSM-IV diagnosis of bipolar disorder, schizophrenia, or other chronic psychotic condition
•Current DSM-IV diagnosis of substance dependence for alcohol, sedative/ hypnotic drugs, stimulants, or cocaine
•Suicidal ideation or behavior requiring immediate attention
•In psychotherapy or in a multidisciplinary pain management program
•Expected surgery in the next 6 months
•Pain thought to be due to cancer, infection, or inflammatory arthritis
•Pregnancy

Locations (1)

Butler Hospital

Providence, Rhode Island, United States

Key Dates

Start Date

November 1, 2012

Primary Completion Date

August 1, 2014

Completion Date

August 1, 2015

Last Updated

October 13, 2022

Enrollment

187

ACTUAL participants

Conditions

Pain InterferenceDepressionAntiretroviral Adherence

Interventions

HIVPASS

BEHAVIORAL

Health Education

OTHER

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 13, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures